Related Experiment Video
Updated: Aug 7, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Generalizable Strategies for the Synthesis of Cereblon-Recruiting PROTAC Prodrugs
Aiden X Wang1, Bin Liu1, Elise M Ackerman1
1Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Chemists developed new prodrug strategies for Cereblon (CRBN)-recruiting proteolysis-targeting chimeras (PROTACs). These methods enable tunable PROTAC release from macromolecular scaffolds, improving targeted protein degradation delivery.
Area of Science:
- Medicinal Chemistry
- Chemical Biology
- Drug Delivery
Background:
- Cereblon (CRBN)-recruiting proteolysis-targeting chimeras (PROTACs) are advanced targeted protein degraders.
- Developing prodrug strategies for CRBN-PROTACs presents significant chemical challenges for effective delivery.
Purpose of the Study:
- To establish generalizable synthetic approaches for creating CRBN-PROTAC prodrugs.
- To demonstrate tunable release kinetics of PROTACs from macromolecular prodrug scaffolds.
Main Methods:
- Developed three orthogonal synthetic strategies: triazole quaternization, tertiary-amine alkylation, and hydroxyl linker installation.
- Incorporated self-immolative linkers with predictable cleavage kinetics.
- Constructed PEGylated macromonomer and bottlebrush prodrug scaffolds.
Main Results:
- Achieved chemoselective and high-yielding syntheses of CRBN-PROTAC prodrugs.
- Demonstrated predictable tuning of PROTAC release rates from macromolecular scaffolds.
- PROTAC-bottlebrush prodrugs showed potency profiles correlating with designed PROTAC release in multiple myeloma models.
Conclusions:
- Established versatile methods for synthesizing CRBN-PROTAC prodrugs.
- Expanded the synthetic possibilities for targeted protein degradation.
- Provided new design principles for controlling degrader activation, selectivity, and in vivo delivery.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
10:20Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production
Published on: October 26, 2018